CAR T cell detection using flow cytometry: versatile solutions for precise results

Chimeric antigen receptors (CARs) are engineered proteins that enable T cells to recognize and target cancer cells, making precise detection essential for advancing CAR T cell therapies.

Built on REAfinity® Recombinant Antibody Technology, our CAR detection portfolio offers reliable solutions to match your needs at every stage, from CAR discovery to analytical assays in cell therapy development. Choose from CAR linker antibodies, antigen-based reagents, or CAR idiotype antibodies, covering a broad range of CAR targets, including CD19, BCMA, CD22, and CD33.

CAR T cell technology explained: structure and function of the CAR receptor

Infographics showing the biological mechanism of CAR T cells binding to antigens on cancer cells.
Structural components of the CAR T receptor.

Each structural component of the CAR plays a vital role in ensuring effective expression, signaling, and function:

  • Extracellular antigen-binding domain: Enables CAR T cells to recognize and bind tumor-associated antigens. Typically, this domain comprises a single-chain variable fragment (scFv), composed of the variable heavy (VH) and variable light (VL) chains of an antibody, connected by a flexible linker.
  • Hinge region and transmembrane domain: Anchor the CAR to the T cell membrane, ensuring stability and receptor function.
  • Signaling domains (e.g., CD28 or 4-1BB): Enhance the T cell persistence, activation, and cytotoxic function.
  • CD3ζ signaling domain: Triggers the immune response upon antigen recognition, driving CAR T cell activation.

Explore our three tailored portfolios of CAR detection reagents

Our CAR detection reagents are engineered with REAfinity® Recombinant Antibody Technology and undergo rigorous quality control throughout development, delivering high precision, exceptional reproducibility, and consistent performance in analytical flow cytometry assays.

Our CAR detection portfolio offers three distinct solution types, each leveraging a different detection strategy to match diverse CAR designs:

  • CAR linker antibodies target conserved CAR linker regions commonly found in CAR constructs.
  • Antigen-based CAR detection reagents detect CARs through their natural antigen.
  • CAR idiotype antibodies recognize unique antibody-derived sequences specific to individual CAR constructs.

All three solution types are compatible with CAR T, CAR NK, and other CAR-engineered cell therapies, supporting flow cytometry assays across all stages of research and cell manufacturing.

Overview of CAR detection reagents

Infographics showing Miltenyi Biotec CAR detection reagentsarrow leftarrow right

We provide a comprehensive range of CAR detection reagents, designed to meet the unique demands of each phase in CAR T cell manufacturing, from discovery to cell therapy workflows.

"Miltenyi Biotec's CAR Detection Reagent has transformed our workflow. It enables fast, reliable flow cytometry CAR detection with a simple protocol, expediting batch release. When integrated with the magnetic cell sorting platform, it allows efficient CAR T enrichment without traditional FACS, saving time and resources."

Dr. Laurens Krekelbergh, MD, Hematology resident and doctoral researcher, University Hospital Antwerp

Choose your fit: dive into the unique features of each portfolio

CAR detection reagentCAR linker antibodiesAntigen-based CAR detection reagentsCAR idiotype antibodies
Detection typeAntibody-basedAntigen-basedAntibody-based
Target binding siteLinker regionAntigen-binding site in the variable scFV regionWithin the variable scFV region
Key characteristics- Broad detection of diverse CAR constructs, independent of antigen specificity
- Reporter-free
- Prove CAR functionality by confirming active binding to specific antigens- Highly specific detection of individual CAR constructs
Main applicationDiscovery
Clinical cell manufacturing workflowsCAR identity testing in clinical cell manufacturing workflows

Infographics showing CAR linker antibodies binding to the linker region of the CAR construct in a CAR T cell.
CAR linker antibodies for broad CAR T cell detection.

CAR linker antibodies

These reagents target the linker region, a conserved structural motif shared across many CAR constructs. This versatility enables fast screening, discovery, and validation, streamlining early-stage research and accelerating the development of promising CAR therapies.

Broad CAR detection: Detect a wide range of CAR T cells, independent of the specific target antigen.

Streamlined translation: Enable direct CAR T cell detection without relying on reporter genes, saving time and freeing up space on the vector for other essential components.

Infographics showing antigen-based CAR detection reagents binding to the antigen-binding site. These CAR detection reagents are available in formats conjugated to biotin (A) for signal amplification using anti-biotin antibodies or conjugated to fluorochromes (B).
Antigen-based CAR detection reagents, available in formats conjugated to biotin (A) and fluorochromes (B).

Antigen–based CAR detection reagents

These recombinant proteins mimic the natural CAR target antigens, binding to the antigen binding site within the CAR's scFv region. For enhanced specificity and flexible detection options, the recombinant protein is fused to the mutated Fc backbone derived from REAfinity Recombinant Technology and conjugated either with biotin (A) or a fluorochrome (B).

Validation of CAR functionality: Proves functional CAR activity by confirming specific antigen binding.

Flexible detection: Available in biotin- or fluorochrome-conjugated formats; the biotin conjugates enable signal amplification with anti-biotin antibodies (REA746).

Infographics showing a CAR idiotype antibody binding to the unique variable scFv region of the CAR construct in a CAR T cell.
CAR idiotype antibodies

CAR idiotype antibodies

Anti-idiotype antibodies specifically recognize the variable scFv region of a CAR, unique for each CAR construct.

Highly specific detection: These antibodies enable precise identification of individual CAR constructs (e.g., FMC63-based CD19 CARs), even when multiple CARs target the same antigen.

Reliable product identity testing: Ideal for confirming the identity of the CAR T cell product, especially in cell manufacturing wokflows where construct specificity and traceability are essential.

Researcher in clean room attire is starting an analysis on the flow cytometer MACSQuant Analyzer 16
Performance and applications

Explore CAR detection performance data and applications

Access the detailed performance data for our CAR detection reagents and discover how CAR detection reagents support reliable analytical workflows in cell therapy applications.

Resources

Webinar

Flow cytometric assays for CAR T cell manufacturing and post-infusion monitoring

In this webinar, we will delve into the crucial role of flow cytometry in analyzing and characterizing critical quality attributes of CAR T cell products, including identity, purity, and potency, throughout the manufacturing process.

Top view on antibody vials with color-coded lids placed in rows
Pretested antibody panels

Ready-to-use antibody panels for CAR T cell analysis

Need a quick solution? Discover Miltenyi Biotec's pretested antibody panels (MBTPs) tailored for precise CAR T cell characterization. Our MBTPs simplify your immunophenotyping workflow, delivering reproducible results for CAR T analysis.

All CAR detection reagents

15 products found

|

You have previously chosen International as your location.
What do you want to do?